Selective dopamine D4 receptor antagonists reverse apomorphine-induced blockade of prepulse inhibition

Psychopharmacology

Volumn 135, Issue 2, 1998, Pages 194-200

  Mansbach, Robert S ^a   Brooks, Elizabeth W ^a   Sanner, Mark A ^a   Zorn, Stevin H ^a  

^a Box 384   (United States)

Author keywords

Clozapine; Dopamine D4 receptor; Prepulse inhibition; Schizophrenia; Startle

Indexed keywords

3 [[4 (4 CHLOROPHENYL) 1 PIPERAZINYL]METHYL] 1H PYRROLO[2,3 B]PYRIDINE; 7 (4 FLUOROPHENOXYMETHYL) 2 (5 FLUORO 2 PYRIMIDINYL) 2,3,4,6,7,8,9,9A OCTAHYDROPYRIDO[1,2 A]PYRAZINE; APOMORPHINE; CLOZAPINE; DOPAMINE 4 RECEPTOR; DOPAMINE RECEPTOR BLOCKING AGENT; HALOPERIDOL; SONEPIPRAZOLE; UNCLASSIFIED DRUG; 3 ((4 (4 CHLOROPHENYL)PIPERAZIN 1 YL)METHYL) 1H PYRROLO(2,3 B)PYRIDINE; 3-((4-(4-CHLOROPHENYL)PIPERAZIN-1-YL)METHYL)-1H-PYRROLO(2,3-B)PYRIDINE; DOPAMINE 2 RECEPTOR; DRD4 PROTEIN, HUMAN; DRD4 PROTEIN, RAT; PIPERAZINE DERIVATIVE; PYRAZINE DERIVATIVE; PYRIDINE DERIVATIVE; PYRIMIDINE DERIVATIVE; PYRROLE DERIVATIVE; SULFONAMIDE;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; MALE; NONHUMAN; PREPULSE INHIBITION; PRIORITY JOURNAL; RAT; SCHIZOPHRENIA; SUBCUTANEOUS DRUG ADMINISTRATION; ANIMAL; CELL LINE; COMPARATIVE STUDY; DRUG EFFECT; HUMAN; METABOLISM; STARTLE REFLEX; WISTAR RAT;

ANIMALS; APOMORPHINE; CELL LINE; DOPAMINE ANTAGONISTS; HUMANS; MALE; PIPERAZINES; PYRAZINES; PYRIDINES; PYRIMIDINES; PYRROLES; RATS; RATS, WISTAR; RECEPTORS, DOPAMINE D2; RECEPTORS, DOPAMINE D4; STARTLE REACTION; SULFONAMIDES;

EID: 0031594510     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002130050501     Document Type: Article

References (27)

1. Braff DL, Stone C, Callaway E, Geyer M, Glick I, Bali L (1978) Prestimulus effects on human startle reflex in normals and schizophrenics. Psychophysiology 15:339-343
2. Bubser M, Koch M (1994) Prepulse inhibition of the acoustic startle response of rats is reduced by 6-hydroxydopamine lesions of the medial prefrontal cortex. Psychopharmacology 113: 487-492
3. 2 dopamine receptor agonists and antagonists on prepulse inhibition of acoustic startle in the rat. Neuropsychopharmacology 12:139-145
4. i) and the concentration of inhibitor which causes 50 percent inhibition (IC50) of an enzymatic reaction. Biochem Pharmacol 22:3099-3108
5. 4-selective dopamine antagonist produces clozapine-like effects on c-fos mRNA and dopamine levels in rat brain. Soc Neurosci Abstr 22:1771
6. Kane J, Honigfeld G, Singer J, Meltzer H, Clozaril Collaborative Study Group (1988) Clozapine for the treatment-resistant schizophrenic. Arch Gen Psychiatry 45:789-796
7. 4 receptor. J Med Chem 39:1941-1942
8. Mansbach RS, Geyer MA (1989) Effects of phencyclidine and phencyclidine biologs on sensorimotor gating in the rat. Neuropsychopharmacology 2:299-308
9. Mansbach RS, Geyer MA, Braff DL (1988) Dopaminergic stimulation disrupts sensorimotor gating in the rat. Psychopharmacology 94:507-514
10. Meador-Woodruff JH, Mansour A, Saul J, Watson SJ (1994) Neuroanatomical distribution of dopamine receptor messenger RNAs. In: Niznik HB (ed) Dopamine receptors and transporters: pharmacology, structure and function. Marcel Dekker, New York, pp 401-414
11. 4 receptor selective antagonist. J Pharmacol Exp Ther 279:1392-1403
12. 2A antagonist MDL 100,907 on disruption of sound and light prepulse inhibition produced by 5-HT agonists in Wistar rats. Psychopharmacology 124:107-116
13. Robertson GS, Matsumura H, Fibiger HC (1994) Induction patterns of Fos-like immunoreactivity in the forebrain as predictors of atypical antipsychotic activity. J Pharmacol Exp Ther 271:1058-1066
14. 4 dopamine receptor binding affinity does not distinguish between typical and atypical antipsychotic drugs. Psychopharmacology 120: 365-368
15. 4. Neuropsychopharmacology 7:261-284
16. 4 receptors bind inactive (+)-aporphines, suggesting neuroleptic role. Sulpiride not stereoselective. Eur J Pharmacol 233:173-174
17. Seeman P, Van Tol HHM (1994) Dopamine receptor pharmacology. Trends Pharmacol Sci 15:264-270
18. Sipes TA, Geyer MA (1994) Multiple serotonin subtypes modulate prepulse inhibition of the startle response in rats. Neuropharmacology 33:441-448
19. Swerdlow NR, Geyer MA (1993) Clozapine and haloperidol in an animal model of sensorimotor gating deficits in schizophrenia. Pharmacol Biochem Behav 44:741-744
20. Swerdlow NR, Braff DL, Masten VL, Geyer MA (1990) Schizophrenic-like sensorimotor gating abnormalities in rats following dopamine infusion into the nucleus accumbens. Psychopharmacology 101:414-420
21. Swerdlow NR, Keith VA, Braff DL, Geyer MA (1991) Effects of spiperone, raclopride, SCH 23390 and clozapine on apomorphine inhibition of sensorimotor gating of the startle response in the rat. J Pharmacol Exp Ther 256:530-536
22. Swerdlow NR, Braff DL, Taaid N, Geyer MA (1994a) Assessing the validity of an animal model of deficient sensorimotor gating in schizophrenic patients. Arch Gen Psychiat 51:139-154
23. Swerdlow NR, Lipska BK, Weinberger DR, Braff DL, Jaskiw GE, Geyer MA (1994b) Increased sensitivity to the sensorimotor gating-disruptive effects of apomorphine after lesions of medial prefrontal cortex or ventral hippocampus in adult rats. Psychopharmacology 122:27-34
24. 4 receptor with high affinity for the antipsychotic clozapine. Nature 350:610-614
25. 2 interactions regulate prepulse inhibition in rats? Neuropsychopharmacol 14:256-274
26. Wolkin A, Sanfilipo M, Wolf AP, Angrist B, Brodie JD, Rotrosen J (1992) Negative symptoms and hypofrontality in chronic schizophrenia. Arch Gen Psychiatry 49:959-965
27. 4 dopamine antagonist with an in vitro and in vivo profile suggestive of an atypical antipsychotic. Soc Neurosci Abstr 22:1771